Inventaire - your friends and communities are your best library

Regulatory considerations for the development of autologous induced pluripotent stem cell therapies

published in: Regenerative Medicine

date of publication: 2010-07-01

Bibliographic databases:

Cites articles 46

Date

Title

Authors

1998-11-06

Embryonic stem cell lines derived from human blastocysts
2003-12-07

Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells

, , ,
2004-12-01

Karyotypic stability, genotyping, differentiation, feeder-free maintenance, and gene expression sampling in three human embryonic stem cell lines derived prior to August 9, 2001.
2004-02-01

Long-term culture of human embryonic stem cells in feeder-free conditions
2006-11-03

Cell therapy and the safety of embryonic stem cell-derived grafts
2006-08-25

Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors

,
2006-04-01

Growth of teratomas derived from human pluripotent stem cells is influenced by the graft site.
2007-11-01

The generation of six clinical-grade human embryonic stem cell lines

,
2007-12-21

Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin
2007-12-21

Induced pluripotent stem cell lines derived from human somatic cells
2007-11-30

Induction of pluripotent stem cells from adult human fibroblasts by defined factors

, , , , ,
2007-07-19

Generation of germline-competent induced pluripotent stem cells

, ,
2007-12-01

Human embryonic stem cells are prone to generate primitive, undifferentiated tumors in engrafted human fetal tissues in severe combined immunodeficient mice
2008-08-01

Pluripotent stem cell lines
2008-02-01

Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development
2008-02-01

Alternative sources of pluripotent stem cells: scientific solutions to an ethical dilemma
2008-07-31

Regulatory issues for personalized pluripotent cells
2008-11

Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes
2008-02-14

Generation of pluripotent stem cells from adult mouse liver and stomach cells

, , , ,
2008-06-29

Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors

, , , ,
2008-12-01

Guidelines and techniques for the generation of induced pluripotent stem cells
2008-02-01

Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming

,
2008-09

Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1

, , , , , , , , , , , , , , , , ,
2008-11-07

Generation of mouse induced pluripotent stem cells without viral vectors
2008-08-24

Regulatory networks define phenotypic classes of human stem cell lines

, ,
2008-02-17

Marked differences in differentiation propensity among human embryonic stem cell lines

, ,
2008-09-01

Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients

, , , , , , , , , , , , , , , , ,
2009-05-14

Emerging ethical, legal and social issues associated with stem cell research & and the current role of the moral status of the embryo

,
2009-12-08

Complete genetic correction of ips cells from Duchenne muscular dystrophy

, , ,
2009-07-01

Developing safe therapies from human pluripotent stem cells
2009-03-18

Generation of induced pluripotent stem cells from human blood

, , , , , , , ,
2009-09-08

Feeder-free derivation of induced pluripotent stem cells from adult human adipose stem cells

, , ,

Article -

Welcome to Inventaire

the library of your friends and communities

learn more